Clinical Trial Update: Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib [Phase 3]

View source ↗

Summary

Phase 3 trial comparing co-administration of pneumococcal vaccine with different combination vaccines; results completed and posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcal Infections

Drugs mentioned

• DTPa-HBV-IPV/Hib (Diphtheria and tetanus toxoids and acellular pertussis vaccine; Hepatitis B vaccine; Inactivated poliovirus vaccine; Haemophilus influenzae type b conjugate vaccine)
• DTPa-IPV/Hib (Diphtheria and tetanus toxoids and acellular pertussis vaccine; Inactivated poliovirus vaccine; Haemophilus influenzae type b conjugate vaccine)
• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 3 | Status: COMPLETED | Results posted: 2018-12-14